Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.43 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16023937 | 0.88 | ALDH1A1 (0.54) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL17685778 | 0.86 | ESR1 (0.53) | MGLLALDH1A1MAPTESR1AKR1C4 | |
| SCHEMBL16154819 | 0.86 | ESR1 (0.53) | MGLLALDH1A1MAPTESR1AKR1C4 | |
| SCHEMBL16013505 | 0.83 | MGLL (0.45) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL22503893 | 0.83 | MGLL (0.45) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL16013504 | 0.83 | MGLL (0.45) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL28593996 | 0.82 | ESR1 (0.49) | ALDH1A1CYP3A4ALOX15TSHRHSD17B10 | |
| SCHEMBL16013471 | 0.80 | MGLL (0.56) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL16013470 | 0.80 | MGLL (0.56) | MGLLALDH1A1MAPTTHRBCNR1 | |
| SCHEMBL23656394 | 0.80 | MGLL (0.42) | MGLLALDH1A1MAPTTHRBCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10792361-B2 | Lipids and lipid compositions for the delivery of active agents | NOVARTIS AG (CH) | 2020-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10792361-B2 | Lipids and lipid compositions for the delivery of active agents | LIPA, LPAR1, LPAR4 | MGLL 28/4885ALDH1A1 2488/4885MAPT 4044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.